Cargando…
Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox
Advanced-stage primary cutaneous T-cell lymphoma has an unfavorable prognosis and low survival rates. Aggressive treatment with chemotherapy is not curative and causes considerable side effects. The combination of bexarotene and denileukin diftitox is associated with an acceptable safety profile and...
Autores principales: | Cervigón-González, Iván, Torres-Iglesias, Luis Miguel, Palomo-Arellano, Ángel, Gil-Pascual, Braulio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175357/ https://www.ncbi.nlm.nih.gov/pubmed/21931572 http://dx.doi.org/10.1159/000324185 |
Ejemplares similares
-
Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
por: Kaminetzky, David, et al.
Publicado: (2008) -
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma
por: Lansigan, Frederick, et al.
Publicado: (2010) -
Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
por: Amagai, Mayuko, et al.
Publicado: (2022) -
Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox
por: Lewis, Daniel J., et al.
Publicado: (2017) -
Cutaneous Mycobacterium abscessus Infection Associated with Mesotherapy Injection
por: Wongkitisophon, Pranee, et al.
Publicado: (2011)